These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 22683647)

  • 41. The effect of material attributes and process parameters on the powder bed uniformity during a low-dose dosator capsule filling process.
    Stranzinger S; Faulhammer E; Calzolari V; Biserni S; Dreu R; Šibanc R; Paudel A; Khinast JG
    Int J Pharm; 2017 Jan; 516(1-2):9-20. PubMed ID: 27826028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers.
    Flament MP; Leterme P; Gayot A
    Int J Pharm; 2004 May; 275(1-2):201-9. PubMed ID: 15081150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a micro dosing system for fine powder using a vibrating capillary. Part 1: the investigation of factors influencing on the dosing performance.
    Chen X; Seyfang K; Steckel H
    Int J Pharm; 2012 Aug; 433(1-2):34-41. PubMed ID: 22595639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Preparation of budesonide sustained-release dry powder for inhalation and influence of lactose content].
    Liang ZL; Wang XH; Ni R; Zhang L; Muenster U; Mao SR
    Yao Xue Xue Bao; 2015 Sep; 50(9):1180-5. PubMed ID: 26757557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhalable lactose-based dry powder formulations of low molecular weight heparin.
    Bai S; Gupta V; Ahsan F
    J Aerosol Med Pulm Drug Deliv; 2010 Apr; 23(2):97-104. PubMed ID: 19778265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Drug/lactose co-micronization by jet milling to improve aerosolization properties of a powder for inhalation.
    Giry K; Péan JM; Giraud L; Marsas S; Rolland H; Wüthrich P
    Int J Pharm; 2006 Sep; 321(1-2):162-6. PubMed ID: 16797150
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modeling dispersion of dry powders for inhalation. The concepts of total fines, cohesive energy and interaction parameters.
    Thalberg K; Berg E; Fransson M
    Int J Pharm; 2012 May; 427(2):224-33. PubMed ID: 22349053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Powder specific active dispersion for generation of pharmaceutical aerosols.
    Crowder T; Hickey A
    Int J Pharm; 2006 Dec; 327(1-2):65-72. PubMed ID: 16930884
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of triboelectric charging in dry powder inhalers using electrical low pressure impactor (ELPI).
    Telko MJ; Kujanpää J; Hickey AJ
    Int J Pharm; 2007 May; 336(2):352-60. PubMed ID: 17218072
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of high shear mixing on ternary dry powder inhaler formulations.
    Hertel M; Schwarz E; Kobler M; Hauptstein S; Steckel H; Scherließ R
    Int J Pharm; 2017 Dec; 534(1-2):242-250. PubMed ID: 29051120
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effervescent dry powder for respiratory drug delivery.
    Ely L; Roa W; Finlay WH; Löbenberg R
    Eur J Pharm Biopharm; 2007 Mar; 65(3):346-53. PubMed ID: 17156987
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of mild processing pressures on the performance of dry powder inhaler formulations for inhalation therapy. 1: Budesonide and lactose.
    Marek SR; Donovan MJ; Smyth HD
    Eur J Pharm Biopharm; 2011 May; 78(1):97-106. PubMed ID: 21182942
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Near InfraRed Spectroscopy homogeneity evaluation of complex powder blends in a small-scale pharmaceutical preformulation process, a real-life application.
    Storme-Paris I; Clarot I; Esposito S; Chaumeil JC; Nicolas A; Brion F; Rieutord A; Chaminade P
    Eur J Pharm Biopharm; 2009 May; 72(1):189-98. PubMed ID: 19059338
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optical diagnostics studies of air flow and powder fluidisation in Nexthaler®. Part II: Use of fluorescent imaging to characterise transient release of fines from a dry powder inhaler.
    Merusi C; Brambilla G; Long EJ; Hargrave GK; Versteeg HK
    Int J Pharm; 2018 Oct; 549(1-2):96-108. PubMed ID: 30017819
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mixing of dry powders for inhalation: A review.
    Spahn JE; Zhang F; Smyth HDC
    Int J Pharm; 2022 May; 619():121736. PubMed ID: 35405281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Centrifugal air-assisted melt agglomeration for fast-release "granulet" design.
    Wong TW; Musa N
    Int J Pharm; 2012 Jul; 430(1-2):184-96. PubMed ID: 22531845
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improvement of flow and bulk density of pharmaceutical powders using surface modification.
    Jallo LJ; Ghoroi C; Gurumurthy L; Patel U; Davé RN
    Int J Pharm; 2012 Feb; 423(2):213-25. PubMed ID: 22197769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lactose characteristics and the generation of the aerosol.
    Pilcer G; Wauthoz N; Amighi K
    Adv Drug Deliv Rev; 2012 Mar; 64(3):233-56. PubMed ID: 21616107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterising surface energy of pharmaceutical powders by inverse gas chromatography at finite dilution.
    Das SC; Stewart PJ
    J Pharm Pharmacol; 2012 Sep; 64(9):1337-48. PubMed ID: 22881445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.